← All trials
NCT05631782
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 10, 2020
- Primary completion
- Dec 25, 2021
- Completion date
- Dec 26, 2021
- First posted
- Nov 30, 2022
- Last posted
- Nov 30, 2022
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The First People’s Hospital of ZunyiLead sponsor
- The First People’s Hospital of ZunyiReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.